dr holst glp 1 Jens Juul of the Novo Nordisk Foundation Center for Basic Metabolic Research and the University of Copenhagen was awarded the 2025 Breakthrough Prize in Life Sciences for his discovery and 🎙️ GLP-1s Target Inflammation for

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under brand names Ozempic and Rybelsus) and chronic weight management (Wegovy)

After hours of cross-country travel, this was the first thing I picked up because I was intrigued by its impressive ingredient list: amino acids and marine algae

1997;273(1 Pt 1):E185-191

While the full benefits of semaglutide GLP-1 may take a few weeks, some people may experience mild changes within the first week

Glucagon-like peptide-1 (GLP-1) is a naturally occurring incretin hormone primarily produced by L-cells in the small intestine, playing a major role in regulating blood sugar levels, appetite, and overall metabolic health